Between studying for my English undergrad and Publishing master's degrees I was out in Shanghai, teaching, learning, and getting extremely lost. Now I'm expanding my mind down a rather different rabbit hole: the pharmaceutical industry. Outside of this job I read mountains of fiction and philosophy, and I must say, it's very hard to tell who's sharper: the literati, or the medicine makers.
February 21, 2023
Mammoth-resurrection company Colossal has spawned a digital pharma entity that wants to take cell and gene therapy to its next stage of evolution
6 min read
January 6, 2023
Two drugs, two different destinies. Does their story prove that business practice makes the difference?
4 min read
January 5, 2023
The International Vaccine Institute is working to make a difference for vaccine manufacture in the world’s less wealthy regions
3 min read
January 9, 2023
Thousands of cell and gene therapy trials are underway, so, assuming at least some success, what can the field do to avoid a seemingly inevitable rush on supporting products and services?
4 min read
January 10, 2023
In the face of war and the lingering economic aftereffects of COVID-19, Europe is weathering an energy price storm. What does this mean for medicine makers?
6 min read
January 18, 2023
Applied correctly, data can do almost anything
6 min read
January 20, 2023
Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why
2 min read
January 24, 2023
New and emerging technologies offer cheaper modes of manufacture – here’s how and why the world’s less wealthy countries could seize the moment
6 min read
January 25, 2023
How a complex but common carbohydrate could help add a new dimension to 3D-printed pills
1 min read
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
